Suppr超能文献

每日三次腹腔注射亚麻醉剂量的氯胺酮可改善成年雌性小鼠的活动限制型厌食症易感性。

Three daily intraperitoneal injections of sub-anesthetic ketamine ameliorate activity-based anorexia vulnerability of adult female mice.

机构信息

Center for Neural Science, New York University, New York, New York, USA.

Neuroscience Institute, NYU Langone Medical Center, New York University, New York, New York, USA.

出版信息

Int J Eat Disord. 2024 Jul;57(7):1447-1464. doi: 10.1002/eat.24036. Epub 2023 Aug 2.

Abstract

OBJECTIVE

To identify ketamine's dosing schedule that ameliorates voluntary food restriction, hyperactivity and body weight loss of adult mice undergoing activity-based anorexia (ABA), an animal model of anorexia nervosa.

METHOD

Female and male C57BL6 mice underwent three cycles of ABA, starting from mid-adolescence. ABA vulnerability was compared within and across two groups of animals: those injected intraperitoneally with 30 mg/kg ketamine for three consecutive days (30mgKetx3) during the second ABA in late adolescence (ABA2) or with vehicle only (Vx3).

RESULTS

Vx3 females and males exhibited individual differences in wheel running and weight retention during first ABA in mid-adolescence (ABA1), ABA2, and third ABA in adulthood (ABA3). Their wheel running correlated with anxiety-like behavior. During ABA1 and ABA3, weight gain of Vx3 females (but not males) after food consumption correlated negatively with food-anticipatory activity (FAA) preceding the feeding hours, indicating that females with higher levels of running restrict feeding more and persistently. This paradoxical relationship confirms earlier findings of ABA females without ketamine treatment, capturing the maladaptive behaviors exhibited by individuals diagnosed with anorexia nervosa. By contrast, 30mgKetx3 had an effect on both sexes of reducing hyperactivity during the feeding hours acutely and reducing anxiety-like behavior's contribution to running. For females, only, 30mgKetx3 acutely improved the extent of compensatory food consumption relative to FAA and improved weight retention during ABA3, 12 days post ketamine in adulthood.

DISCUSSION

Sub-anesthetic ketamine evokes behavior-specific ameliorative effects for adult mice re-experiencing ABA, supporting the notion that multiple doses of ketamine may be helpful in reducing relapse among adults with anorexia nervosa.

PUBLIC SIGNIFICANCE STATEMENT

This study examined whether ketamine reduces anorexia-like behaviors in adult mice. Three daily sub-anesthetic ketamine injections suppress wheel running during and leading up to the hours of food availability and enable animals to compensate better for weight loss associated with excessive exercise by eating more. These findings suggest that ketamine may help adult females diagnosed with anorexia nervosa but also point to sex- and age-related differences in the action of ketamine.

摘要

目的

确定氯胺酮的给药方案,以改善经历基于活动的厌食症(ABA)的成年小鼠的自愿节食、多动和体重减轻,ABA 是厌食症的动物模型。

方法

雌性和雄性 C57BL6 小鼠在青春期中期开始经历三个 ABA 周期。在两组动物中比较 ABA 易感性:一组在青春期后期(ABA2)的第二个 ABA 期间连续三天腹膜内注射 30mg/kg 氯胺酮(30mgKetx3),另一组仅注射载体(Vx3)。

结果

Vx3 雌性和雄性在青春期中期(ABA1)、青春期后期(ABA2)和成年期第三个 ABA(ABA3)期间的第一轮 ABA 中表现出轮跑和体重保留的个体差异。他们的轮跑与焦虑样行为相关。在 ABA1 和 ABA3 期间,Vx3 雌性(但不是雄性)在进食后体重增加与进食前的食物预期活动(FAA)呈负相关,表明跑步水平较高的雌性进食限制更多且更持续。这种矛盾的关系证实了之前没有氯胺酮治疗的 ABA 雌性的发现,捕捉到了被诊断为厌食症患者的适应性行为。相比之下,30mgKetx3 对雄性和雌性都有减少喂食时间内多动的作用,并减少焦虑样行为对跑步的贡献。仅对雌性而言,30mgKetx3 急性改善了相对于 FAA 的补偿性食物摄入程度,并在 ABA3 期间改善了体重保留,成年后接受氯胺酮治疗 12 天。

讨论

亚麻醉剂量的氯胺酮对重新经历 ABA 的成年小鼠产生特定于行为的改善作用,支持多次氯胺酮治疗可能有助于减少厌食症成年人的复发的观点。

公众意义声明

本研究检查了氯胺酮是否能减少成年小鼠的厌食样行为。每日三次亚麻醉氯胺酮注射可抑制喂食期间和喂食前的轮跑,并使动物通过多吃更好地补偿与过度运动相关的体重减轻。这些发现表明,氯胺酮可能对诊断为厌食症的成年女性有帮助,但也指出了氯胺酮作用的性别和年龄相关差异。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验